+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transplant Diagnostics Market - Global Forecast 2026-2032- Product Image
Transplant Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Transplant Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986098
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Transplant diagnostics is transforming patient management by giving healthcare organizations and laboratories critical clinical insights and operational efficiencies. As demands for precision and resilience accelerate, leaders must strategically align technology implementation, procurement, and workflow integration to succeed in this evolving market.

Market Snapshot: Transplant Diagnostics Market Size and Growth

The Transplant Diagnostics Market is demonstrating robust and sustained expansion. In 2025, the market was valued at USD 6.78 billion, rising to USD 7.20 billion in 2026. With a projected compound annual growth rate (CAGR) of 7.03%, it is anticipated to reach USD 10.92 billion by 2032. Market momentum is propelled by the increasing requirement for precision-driven transplantation tools, the growing adoption of advanced molecular techniques, and enhanced testing protocols tailored to contemporary healthcare demands.

Scope & Segmentation

  • Diagnostic Applications: Includes donor-recipient matching, ongoing graft monitoring, high and low-resolution HLA typing, and thorough infectious disease screening targeting bacterial, fungal, and viral agents, such as Cytomegalovirus, Epstein Barr Virus, hepatitis, and HIV.
  • Enabling Technologies: Encompasses advanced enzymatic assays, flow cytometry, and both digital and quantitative polymerase chain reaction (PCR) platforms, in addition to next-generation and Sanger sequencing methods.
  • Organ Types: Spans transplantation diagnostics for heart, kidney, liver, lung, and pancreas settings, supporting diverse clinical objectives and operational procedures.
  • End Users: Serves diagnostic labs, private and public hospitals, research institutes, and standalone transplant centers, each possessing distinct integration and workflow requirements.
  • Regions: Encompasses the Americas, Europe, Middle East & Africa, and Asia-Pacific, capturing regional business diversity and regulatory frameworks.

Segment intersections reflect evolving clinical requirements, technological readiness, and varied infrastructure maturity. For example, uptake of high-throughput PCR and sequencing enables efficient processing of greater sample volumes, benefiting high-demand clinical environments. Procurement standards, data governance, and compliance needs differ by market maturity, affecting technology adoption paths. Hospitals, prioritizing clinical integration, are often distinct from independent labs that favor automation and analytical breadth. Dynamic local policy and funding models play a vital role in shaping segment growth and technology deployment speed.

Key Takeaways: Strategic Insights for the Transplant Diagnostics Market

  • Molecular and immunological innovation is enhancing both pre- and post-transplant evaluations by improving test sensitivity and reducing result turnaround, supporting more agile and adaptive patient management.
  • Diagnostics now drive core transplant workflows, leading to increased demand for comprehensive evidence bases and IT system integration within clinical operations.
  • Procurement and laboratory leaders seek multipurpose platforms capable of direct health record integration, workflow optimization, and validated, payer-relevant outcomes.
  • Collaborative industry models facilitate bundled solutions, accelerating adoption by leveraging partnerships among manufacturers, suppliers, and clinical entities for mutual study validation.
  • Regional diversity in infrastructure, reimbursement, and procurement drives opportunities for global platform providers as well as local solution specialists.
  • Supply chain resilience is a priority as evolving compliance and reimbursement conditions prompt diversified sourcing and inventory strategies to support operational stability.

Tariff Impact: Supply Chain and Procurement Considerations

Tariffs imposed in 2025 have elevated acquisition costs across reagents, consumables, and diagnostic instrumentation, directly affecting the transplant diagnostics sector. Procurement leaders are responding by broadening supplier networks, evaluating dual-sourcing and nearshoring models, and investing in transparent supply chain mapping to improve cost management and continuity. Such strategies enhance organizational resilience and enable consistent clinical delivery in fluctuating regulatory environments.

Methodology & Data Sources

Insights in this report are based on comprehensive interviews with transplant clinicians, laboratory directors, and procurement managers, as well as systematic reviews of peer-reviewed literature, regulatory filings, and clinical trial datasets. Sector-specific analyses examined assay performance, systemic integration, and supply dependencies. Final findings were validated by expert advisors and cross-referenced with post-market surveillance.

Why This Report Matters

  • Delivers actionable analysis for stakeholders involved in technology evaluation, operational planning, and business growth in the transplant diagnostics landscape.
  • Enables organizations to anticipate critical procurement and supply chain challenges, forge robust partnerships, and demonstrate value for improved market access and reimbursement outcomes.
  • Supports investment and commercialization roadmaps by providing focused intelligence on drivers, adoption influencers, and ecosystem opportunities in diverse global markets.

Conclusion

Transplant diagnostics is advancing toward more connected, evidence-based operational models. Decision-makers who align clinical expertise, technology selection, and supply chain strategy can achieve improved patient outcomes and operational resilience across continually shifting healthcare settings.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Transplant Diagnostics Market, by Diagnostic Application
8.1. Donor Recipient Matching
8.2. Graft Monitoring
8.3. Hla Typing
8.3.1. High Resolution
8.3.2. Low Resolution
8.4. Infectious Disease Screening
8.4.1. Bacterial Screening
8.4.2. Fungal Screening
8.4.3. Viral Screening
8.4.3.1. Cytomegalovirus
8.4.3.2. Epstein Barr Virus
8.4.3.3. Hepatitis Viruses
8.4.3.4. Hiv
9. Transplant Diagnostics Market, by Technology
9.1. Enzymatic Assays
9.2. Flow Cytometry
9.3. Pcr
9.3.1. Digital Pcr
9.3.2. Qpcr
9.4. Sequencing
9.4.1. Next Generation
9.4.2. Sanger
10. Transplant Diagnostics Market, by Organ Type
10.1. Heart
10.2. Kidney
10.3. Liver
10.4. Lung
10.5. Pancreas
11. Transplant Diagnostics Market, by End User
11.1. Diagnostic Laboratories
11.2. Hospitals
11.2.1. Private Hospitals
11.2.2. Public Hospitals
11.3. Research Institutes
11.4. Transplant Centers
12. Transplant Diagnostics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Transplant Diagnostics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Transplant Diagnostics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Transplant Diagnostics Market
16. China Transplant Diagnostics Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Adaptive Biotechnologies Corporation
17.7. altona Diagnostics GmbH
17.8. Arquer Diagnostics Ltd.
17.9. BAG Group
17.10. Becton, Dickinson and Company
17.11. Bio-Rad Laboratories, Inc.
17.12. Biogenuix Medsystems Pvt. Ltd
17.13. BioMérieux SA
17.14. Bruker Corporation
17.15. Caredx Inc.
17.16. CareDx, Inc.
17.17. CLONIT srl
17.18. Diagnóstica Longwood SL
17.19. DiaSorin S.p.A.
17.20. Eurofins Scientific SE
17.21. F. Hoffmann-La Roche Ltd.
17.22. Genome Diagnostics B.V.
17.23. Hologic, Inc.
17.24. Illumina, Inc
17.25. Immucor, Inc.
17.26. Laboratory Corporation of America Holdings
17.27. Luminex Corporation
17.28. Merck KGaA
17.29. NanoString Technologies, Inc.
17.30. Novartis AG
17.31. PathoNostics B.V
17.32. QIAGEN, N.V.
17.33. Quest Diagnostics Incorporated
17.34. Randox Laboratories Ltd.
17.35. Takara Bio Inc.
17.36. Thermo Fisher Scientific Inc.
17.37. TransMedics, Inc.
17.38. Zimmer Biomet Group
List of Figures
FIGURE 1. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DONOR RECIPIENT MATCHING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DONOR RECIPIENT MATCHING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DONOR RECIPIENT MATCHING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GRAFT MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GRAFT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GRAFT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIGH RESOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIGH RESOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIGH RESOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LOW RESOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LOW RESOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LOW RESOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY BACTERIAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY BACTERIAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY BACTERIAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FUNGAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FUNGAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FUNGAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CYTOMEGALOVIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CYTOMEGALOVIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CYTOMEGALOVIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY EPSTEIN BARR VIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY EPSTEIN BARR VIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY EPSTEIN BARR VIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEPATITIS VIRUSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEPATITIS VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEPATITIS VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HIV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ENZYMATIC ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ENZYMATIC ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ENZYMATIC ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SANGER, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SANGER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SANGER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEART, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEART, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEART, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LUNG, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LUNG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PANCREAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PANCREAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 156. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 157. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 158. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 160. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 161. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 175. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 178. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 179. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 180. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 182. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 183. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 201. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 202. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 203. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 205. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 206. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 207. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 209. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 212. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 213. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 214. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 215. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 216. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 217. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 218. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 231. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 234. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 235. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 236. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 238. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 239. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 240. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 242. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 245. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 246. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 247. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 249. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 250. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 251. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 253. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 256. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 257. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 258. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 259. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 260. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 261. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 262. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 263. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 264. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 276. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 277. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 278. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
TABLE 279. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 280. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
TABLE 281. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 282. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 283. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 284. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
TABLE 285. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 286. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Transplant Diagnostics market report include:
  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • altona Diagnostics GmbH
  • Arquer Diagnostics Ltd.
  • BAG Group
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biogenuix Medsystems Pvt. Ltd
  • BioMérieux SA
  • Bruker Corporation
  • Caredx Inc.
  • CareDx, Inc.
  • CLONIT srl
  • Diagnóstica Longwood SL
  • DiaSorin S.p.A.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics B.V.
  • Hologic, Inc.
  • Illumina, Inc
  • Immucor, Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Merck KGaA
  • NanoString Technologies, Inc.
  • Novartis AG
  • PathoNostics B.V
  • QIAGEN, N.V.
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransMedics, Inc.
  • Zimmer Biomet Group

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.2 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.92 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned35

Related Topics

Related Reports

Transplant Diagnostics Market Report Size, Share, Trends and Forecast by Component, Technology, Organ Type, Application, End User, and Region, 2025-2033 - Product Image

Transplant Diagnostics Market Report Size, Share, Trends and Forecast by Component, Technology, Organ Type, Application, End User, and Region, 2025-2033

  • Report
  • 148 Pages
  • Global
From
Transplant Diagnostics Market Report and Forecast 2025-2034 - Product Image

Transplant Diagnostics Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Transplant Diagnostics Market Forecast to 2033 - Product Image

Transplant Diagnostics Market Forecast to 2033

  • Report
  • 150 Pages
  • Global
From
Transplant Diagnostics Market Report 2025 - Product Image

Transplant Diagnostics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Serological Transplant Diagnostics - Global Strategic Business Report - Product Image

Serological Transplant Diagnostics - Global Strategic Business Report

  • Report
  • 161 Pages
  • Global
From

About the Transplant Diagnostics Market

The Transplant Diagnostics market is a subset of the Diagnostics industry, which focuses on the development and commercialization of tests and technologies used to diagnose and monitor transplant patients. These tests are used to detect and monitor the presence of donor-derived cells, as well as to assess the risk of rejection and other complications. Transplant Diagnostics also includes tests used to detect and monitor infections, such as viruses and bacteria, that can be transmitted through transplanted organs. The Transplant Diagnostics market is driven by the increasing number of organ transplants, as well as the need for improved patient outcomes. Additionally, the development of new technologies and tests, such as next-generation sequencing and mass spectrometry, has enabled more accurate and timely diagnosis and monitoring of transplant patients. Some companies in the Transplant Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Cepheid, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.